Infectious Disease · Medical Literature
[Comment] Tuberculosis needs a multidimensional definition to spur thinking and action
Abstract
Dorland’s Medical Dictionary defines tuberculosis as any of the infectious diseases caused by species of Mycobacterium and characterised by tubercle formation with caseous necrosis in the tissues.1 Similar microbe-centric definitions that leave many questions about epidemiology, pathogenesis, clinical features, and outcomes unanswered appear in many medical textbooks. Such definitions do not adequately explain the variation in tuberculosis burden, morbidity, and mortality across countries, and why only 5–10% of the quarter of the world’s population with tuberculosis infection develop active disease during their lifetime.
Clinical relevance
Does the prevailing microbe-centric definition of tuberculosis adequately explain the global variation in TB burden, morbidity, mortality, and the immunological puzzle of why only a minority of infected individuals develop active disease, and should a multidimensional definition be adopted to better orient thinking, research, and public health action? __SNAPSHOT__ {"studyDesign":"Expert commentary / opinion piece (not an original research study; no primary data collected or analyzed)","setting":"Not applicable — conceptual and epidemiological argument; journal: The Lancet Microbe (2026)","sampleSize":"Not applicable","population":"Implicit population of concern: all individuals with Mycobacterium tuberculosis infection globally, with particular relevance to high-burden, low- and middle-income country settings","intervention":"Proposed conceptual reframing: adoption of a multidimensional (rather than microbe-centric) definition of tuberculosis","comparator":"Current standard microbe-centric definitions (e.g., Dorland's Medical Dictionary; major medical textbooks)","primaryOutcome":"Not applicable — no quantitative primary endpoint; the authors argue that the existing definitional framework is insufficient to explain TB epidemiology and advocate for a broader conceptual model","followUp":"Not applicable","fundingSource":"Not reported"}
Key findings
This commentary does not report original empirical data, p-values, effect sizes, or confidence intervals. The central argument is that microbe-centric definitions of tuberculosis — typified by Dorland's characterization as an infectious disease caused by Mycobacterium species and characterized by tubercle formation with caseous necrosis — fail to account for observed variation in TB burden, morbidity, and mortality across countries and populations. The authors highlight the well-established epidemiological observation that only approximately 5–10% of the estimated quarter of the world's population with latent TB infection ever develop active disease during their lifetime, a fact irreconcilable with a purely microbiological framing. No NNT, NNH, absolute risk reduction, or other quantitative treatment effect is presented, as none is applicable to this article type.
Practice implications
This commentary establishes a conceptual critique rather than an empirical finding. The authors assert that standard microbe-centric TB definitions leave critical questions about epidemiology, pathogenesis, clinical heterogeneity, and outcomes unanswered — and implicitly argue that integrating social, nutritional, immunological, and structural determinants into the definitional framework is necessary to guide more effective thinking and intervention. What the piece does NOT establish: it does not propose or validate a specific alternative definition; it does not test clinical outcomes under any alternative framework; and it does not provide new epidemiological data. The argument applies broadly to global TB policy, clinical education, and research agenda-setting. High-income, low-burden settings may perceive limited immediate applicability, whereas the argument is most salient for high-burden, resource-limited contexts. Because only an abstract was provided and the full commentary text is unavailable, the completeness and strength of the authors' proposed multidimensional model cannot be fully evaluated. Clinicians and policymakers should read the full article before drawing operational conclusions. __LIMITATIONS__ 1. Study design: Expert opinion/commentary — the lowest tier of evidence in evidence-based medicine hierarchies; no original data, no control condition, no hypothesis testing. 2. Abstract-only availability: The specific multidimensional definition proposed, supporting arguments, and cited evidence cannot be fully assessed from the abstract alone. 3. Absence of operationalization: A multidimensional definition's clinical utility depends on whether it can be operationalized in diagnostic, prognostic, or therapeutic practice — this is not demonstrated in the abstract. 4. Potential for ideological framing: Commentary articles are inherently subject to author viewpoint and selective citation; independent critical appraisal of the full text is essential. 5. Generalizability of the critique: The inadequacy of microbe-centric definitions may be more pronounced in certain epidemiological and socioeconomic contexts and less relevant in others. 6. No patient-level data: The 5–10% lifetime progression estimate cited is a well-known approximation with heterogeneity across populations; its invocation as a rhetorical anchor does not itself validate a new definitional model. __BOTTOM_LINE_CATEGORY__ promising_but_preliminary __BOTTOM_LINE__ Bhargava and Bhargava argue in this Lancet Microbe commentary that microbe-centric TB definitions are conceptually insufficient to explain global variation in TB burden or the observation that only 5–10% of latently infected individuals develop active disease, and they call for adoption of a multidimensional definition. This is an expert opinion piece with no primary data, and while the conceptual critique is clinically resonant — particularly for educators, policymakers, and researchers — no immediate change in diagnostic or treatment practice is warranted based on a commentary alone. Clinicians and curriculum developers should engage with the full article and weigh it within the broader literature on TB's social, nutritional, and immunological determinants.